Linda A. Fitzpatrick
Net Worth

Last updated:

What is Linda A. Fitzpatrick net worth?

The estimated net worth of Ms. Linda A. Fitzpatrick is at least $3,582,495 as of 5 Mar 2024. She owns shares worth $7,755 as insider and has received compensation worth at least $3,574,740 in Sutro Biopharma, Inc..

What is the salary of Linda A. Fitzpatrick?

Ms. Linda A. Fitzpatrick salary is $595,790 per year as Chief People & Communications Officer in Sutro Biopharma, Inc..

How old is Linda A. Fitzpatrick?

Ms. Linda A. Fitzpatrick is 68 years old, born in 1957.

What stocks does Linda A. Fitzpatrick currently own?

As insider, Ms. Linda A. Fitzpatrick owns shares in one company:

Company Title Shares Price per share Total value
Sutro Biopharma, Inc. (STRO) Chief People & Communications Officer 9,007 $0.86 $7,755

What does Sutro Biopharma, Inc. do?

Sutro Biopharma, Inc. operates as clinical stage drug discovery, development, and manufacturing company. It focuses on creating protein therapeutics for cancer and autoimmune disorders through integrated cell-free protein synthesis and site-specific conjugation platform, XpressCF+.The company's product candidates include STRO-001, an antibody-drug conjugate (ADC) directed against the cancer target CD74 for patients with multiple myeloma and non-Hodgkin lymphoma that is in Phase 1 clinical trials; and STRO-002, an ADC directed against folate receptor-alpha for patients with ovarian and endometrial cancers, which is in Phase 1 clinical trials. It has collaboration and license agreements with Merck Collaboration to develop research programs focusing on cytokine derivatives for cancer and autoimmune disorders; and Celgene Corporation to discover and develop bispecific antibodies and/or ADCs focused on the field of immuno-oncology. The company was formerly known as Fundamental Applied Biology, Inc. Sutro Biopharma, Inc. was incorporated in 2003 and is headquartered in South San Francisco, California.

STRO logo
STRO
Sutro Biopharma, Inc.
$0.86

Linda A. Fitzpatrick insider trading

Sutro Biopharma, Inc.

Transaction Date Security Shares Price per share Total value Source
Option
Restricted Stock Unit (RSU) 8,750 N/A N/A
Option
Common Stock 8,750 N/A N/A
Option
Restricted Stock Unit (RSU) 9,125 N/A N/A
Option
Common Stock 9,125 N/A N/A
Option
Common Stock 6,875 N/A N/A
Option
Restricted Stock Unit (RSU) 6,875 N/A N/A
Option
Restricted Stock Unit (RSU) 8,250 N/A N/A
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Unit (RSU) 9,125 N/A N/A
Option
Common Stock 8,750 N/A N/A
Option
Common Stock 9,125 N/A N/A
Option
Restricted Stock Unit (RSU) 8,750 N/A N/A
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Unit (RSU) 8,250 N/A N/A
Option
Common Stock 8,750 N/A N/A
Option
Restricted Stock Unit (RSU) 8,750 N/A N/A
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Unit (RSU) 8,250 N/A N/A
Option
Restricted Stock Unit (RSU) 7,576 N/A N/A
Option
Common Stock 7,576 N/A N/A
Option
Common Stock 8,250 N/A N/A
Option
Restricted Stock Unit (RSU) 8,250 N/A N/A
Option
Common Stock 1,652 $4.36 $7,203
Option
Stock Option (right to buy) 1,652 $4.36 $7,203
Option
Restricted Stock Unit (RSU) 7,576 N/A N/A
Option
Common Stock 7,576 N/A N/A
Purchase
Common Stock 3,225 N/A N/A
Option
Common Stock 7,575 N/A N/A
Option
Restricted Stock Unit (RSU) 7,575 N/A N/A
Option
Common Stock 826 N/A N/A
Option
Stock Option (right to buy Common Stock) 826 N/A N/A

Sutro Biopharma key executives

Sutro Biopharma, Inc. executives and other stock owners filed with the SEC: